天坛生物下属公司获药品GMP符合性检查告知书

Core Viewpoint - TianTan Bio (600161.SH) announced that its subsidiary Chengdu Rongsheng Pharmaceutical Co., Ltd. received a "Drug GMP Compliance Inspection Notification" from the Sichuan Provincial Drug Administration, specifically concerning the production workshop for recombinant products [1] Group 1 - The notification indicates compliance with Good Manufacturing Practice (GMP) standards, which is crucial for the production of pharmaceutical products [1] - The involved workshop is dedicated to the production of recombinant products, highlighting the company's focus on advanced biopharmaceutical manufacturing [1]